The Catalyst Manufacturing Center focuses on innovative research for the manufacturing of catalysts, and the education of a new generation of researchers in theoretical tools that can be applied to catalyst manufacturing. Catalysts are essential for many industrial processes, ranging from catalytic converters to the production of chemicals and pharmaceuticals. Catalyst manufacturing processes are often designed relying on empiricism, leading to sub-optimal processes, decreased quality, and increased cost. By combining the substantial level of expertise in particle technology, optimization, multi-scale simulation, catalysis and molecular modeling available at Rutgers, we are developing science-based methods for designing and optimizing catalyst manufacturing operations such as impregnation, drying and calcination.
The PhD Training Program in Biotechnology at Rutgers, The State University of New Jersey, and the Robert Wood Johnson Medical School of the University of Medicine and Dentistry of NJ (UMDNJ) was established in 1989. It is one of the select group of such programs throughout the country funded by the National Institute of Health (NIH). The 2008-09 year marks the 19th year of NIH funding.
The aim of the program is to train a new breed of creative investigators who are able to translate basic science discoveries into technology developments for the needs of society, government, and industry. Students in the program; (1) become well educated within a single biotechnology-related discipline (e.g. biochemistry, chemical engineering, molecular biology), and (2) become fluent in the language, approaches and principles of the biological and physical sciences, in general.
New Jersey is home to a large number of global pharmaceutical and medicinal manufacturing companies and Rutgers University is located at the national epicenter of pharmaceutical research and development. The pharmaceutical industry is increasingly looking for engineers and pharmaceutical scientists with advanced training in pharmaceutical engineering. Rutgers' provides an intellectual climate for the preparation of individuals for professional advancement and will train engineers and scientists with the requisite skills to work in the rapidly evolving regulatory framework that determines pharmaceutical product design and manufacturing processes.
The Center for Structure Organic Particulate Systems (C-SOPS) brings together a cross-disciplinary team of engineers and scientists, as well as industry leaders, to improve the way pharmaceuticals, foods and agricultural products are manufactured. C-SOPS will focus on advancing the scientific foundation for the optimal design of SOPS with advanced functionality while developing the methodologies for their active control and manufacturing. Joining Rutgers University in the Center are Purdue University, the New Jersey Institute of Technology and the University of Puerto Rico at Mayaguez, schools with established teaching and research programs in engineering, pharmaceutical sciences and technology.
Rutgers is the home to a Research Experience for Undergraduates (REU) site on Advanced Materials. This program is supported by a grant from the National Science Foundation and serves a diverse population of students to whom cutting-edge research experiences are not typically available and thus broadens the pipeline to graduate school for a wide range of students. The current program is led by Professors Meenakshi Dutt (PI) of the Chemical and Biochemical Engineering Department and Deirdre O’Carroll (co-PI) of the Materials Science and Engineering Department. The interdisciplinary nature of this REU provides opportunities for undergraduate students to carry out research in a broad array of advanced materials such as nanomaterials, hybrid soft materials, patterned surfaces, glasses, inorganic polymers, and advanced ceramic composites.